Home » Topics » BioWorld Science

BioWorld Science
RSS

NeuroSearch patents nACh receptor modulators

Aug. 28, 2001

Research at Amgen leads to the discovery of new integrin antagonists

Aug. 28, 2001

Bone-targeting compounds in the Ariad pipeline

Aug. 28, 2001

Potent and selective integrin inhibitors reported by Celltech

Aug. 28, 2001

BMS patents compounds having unique dopaminergic and serotonergic activity

Aug. 28, 2001

Selective epoxyketone inhibitors developed at Yale University

Aug. 28, 2001

Demegen receives grant in support of P-113D development for cystic fibrosis infections

Aug. 28, 2001

Novel cytokine production inhibitors highlighted at the ongoing ACS meeting

Aug. 28, 2001

Pharmacia presents a potent MMP inhibitor at ACS meeting in Chicago

Aug. 28, 2001

Oral suspension formulation of Trileptal soon to be available in Europe

Aug. 28, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...